Gools, I would have thought that was a relatively low PE in reality. Also I think Aspen are looking to the future of the generics business in Australia.
If I remember correctly there are some very big drugs to be released into the generic market over the next 3/4 years.
I think Aspen are getting a pretty good deal really.
Add to My Watchlist
What is My Watchlist?